NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-HS-24-013 from the NIH Guide for Grants and Contracts
Notice NOT-HL-24-004 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-24-200 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NINDS R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs.
Notice NOT-EB-24-009 from the NIH Guide for Grants and Contracts
Notice NOT-NS-24-086 from the NIH Guide for Grants and Contracts
Notice NOT-CA-24-051 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HG-24-005 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity Announcement (NOFO) is to solicit applications for the Coordinating Center (CC) of the ML/AI Tools to Advance Genomic Translational Research (MAGen) Consortium. In collaboration with the MAGen Sites funded by the companion NOFO (RFA-HG-24-004) the CC will explore the feasibility of developing Machine Learning (ML) and Artificial Intelligence (AI) tools that can enhance the accuracy and precision of predicting how individuals with pathogenic genetic variants manifest disease. The CC will be responsible for implementing approaches to bring diverse teams together to enable synergistic and collaborative team science across the Consortium. Specifically, the CC will be responsible for technical, scientific, and administrative coordination activities to support the Consortium research activities including development of consortium wide plans, coordinated ELSI-informed ML/AI tool development and cross validation, and dissemination of the developed resources.
Funding Opportunity RFA-HG-24-004 from the NIH Guide for Grants and Contracts. NHGRI aims to setup a research Consortium, ML/AI Tools to Advance Genomic Translational Research (MAGen), to collaboratively explore the feasibility of developing Machine Learning (ML) and Artificial Intelligence (AI) tools that can enhance the accuracy and precision of predicting how individuals with pathogenic genetic variants manifest disease. The primary goal is to identify both genomic and non-genomic factors influencing disease development in individuals carrying pathogenic genetic variants. The ML/AI tools will leverage existing multimodal genomic and non-genomic data and will be cross validated in genomic translational research settings to ensure the accuracy and generalizability of the tools for translational purposes. In addition, the Consortium will explore the ethical, legal, and social implications (ELSI) of integrating ML/AI tools into genomic medicine through the establishment of an ELSI Framework for their development, and through implementation of ELSI research projects.
Notice NOT-NS-24-074 from the NIH Guide for Grants and Contracts
Notice NOT-CA-24-049 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HL-25-009 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications to enhance the pool of highly trained investigators from diverse backgrounds, including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations. This NOFO invites applications from institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators. This NOFO is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial. Applicants to this NOFO are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary study to an ongoing clinical trial as lead investigator should apply to the companion NOFO (see RFA-HL-25-008).
Funding Opportunity RFA-HL-25-008 from the NIH Guide for Grants and Contracts. Purpose This Notice of Funding Opportunity (NOFO) invites applications to enhance the pool of highly trained investigators from diverse backgrounds, including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations. This NOFO invites applications from institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators. This NOFO is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial. Applicants to this NOFO are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary study to an ongoing clinical trial as lead investigator should apply to the companion NOFO (see RFA-HL-25-009).
Funding Opportunity RFA-AR-25-002 from the NIH Guide for Grants and Contracts. Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
Notice NOT-HS-24-014 from the NIH Guide for Grants and Contracts
Notice NOT-GM-24-031 from the NIH Guide for Grants and Contracts
Notice NOT-OD-24-123 from the NIH Guide for Grants and Contracts
Notice NOT-OD-24-122 from the NIH Guide for Grants and Contracts
Notice NOT-MH-24-315 from the NIH Guide for Grants and Contracts
Notice NOT-AI-24-052 from the NIH Guide for Grants and Contracts
Notice NOT-MH-24-295 from the NIH Guide for Grants and Contracts